首页> 外文期刊>International Urology and Nephrology >Variation of clinical and laboratory features in chronic dialysis patients treated with high-flux hemodialysis after switching to online hemodiafiltration
【24h】

Variation of clinical and laboratory features in chronic dialysis patients treated with high-flux hemodialysis after switching to online hemodiafiltration

机译:改用在线血液透析滤过后,接受高通量血液透析治疗的慢性透析患者的临床和实验室特征的变化

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose: The study of online hemodiafiltration (HDF) benefits over high-flux hemodialysis (HD) raises great interest. The purpose was to compare clinical and laboratory parameters in patients treated with HD who were switched to HDF. Methods: Forty-eight HD patients (study group) were switched to HDF, while other 521 patients remained on HD as a control group. During last 6 HD months and during first year of HDF, we determined in both groups the following parameters: monthly-weekly dialysis time, systolic and diastolic blood pressure, body mass index (BMI), interdialytic body weight gain (IBWG), blood flow rate (Qb), weekly erythropoietin-stimulating agents dose (EPO), single-pool Kt/V, calcium, phosphorus (P), hemoglobin and normalized protein catabolic ration (nPCR), plus every 3 months - albumin, parathormone (PTH), ferritin and transferrin saturation (TSAT). In both groups, parameters in the last 6 HD months were compared to those in the first 6 months and, respectively, to those in the first year of HDF. Results: In the study group, albumin and nPCR were significantly higher in the HD period not only compared to the first 6 months of HDF, but also compared to the first year of HDF. IBWG and P were higher with HD compared to the first year of HDF, but not with the first 6 months. PTH, Kt/V, Qb and EPO were higher in both HDF periods. In the control group, albumin was significantly higher in the first 6 months after the switch, but it was significantly lower in the first year. BMI, ferritin, PTH, Kt/V, Qb, TSAT and weekly dialysis time were higher in both HDF periods, while nPCR, EPO, SBP and DBP were lower. IBWG and Hb rose only during the first year after the switch, while P was lower in the first year, but not in the first 6 months. Conclusions: Nutrition, assessed by albumin, nPCR and BMI, was not improved by HDF compared to HD. With HDF, Kt/V and phosphorus control were better, similar results were observed in the control group. A larger EPO dose was needed with HDF for maintaining a similar hemoglobin level.
机译:目的:研究在线血液透析滤过(HDF)优于高通量血液透析(HD)的兴趣。目的是比较转为HDF的接受HD治疗的患者的临床和实验室参数。方法:将48例HD患者(研究组)转换为HDF,而其他521例患者仍保留HD作为对照组。在HD的最近6个月和HDF的第一年中,我们在两组中确定以下参数:每月一次的透析时间,收缩压和舒张压,体重指数(BMI),透析间体重增加(IBWG),血流量率(Qb),每周促红细胞生成素刺激剂剂量(EPO),单池Kt / V,钙,磷(P),血红蛋白和标准化蛋白分解率(nPCR),以及每3个月加一次-白蛋白,副甲状腺激素(PTH) ,铁蛋白和转铁蛋白饱和度(TSAT)。在两组中,将HD的最近6个月中的参数与HDF的前6个月中的参数以及HDF的第一年中的参数分别进行比较。结果:在研究组中,HD期的白蛋白和nPCR不仅显着高于HDF的前6个月,而且也高于HDF的第一年。与HDF的第一年相比,HD的IBWG和P更高,但开始的6个月则没有。在两个HDF期间,PTH,Kt / V,Qb和EPO均较高。在对照组中,转换后的前6个月白蛋白显着升高,但在第一年中白蛋白显着降低。在两个HDF期间,BMI,铁蛋白,PTH,Kt / V,Qb,TSAT和每周透析时间均较高,而nPCR,EPO,SBP和DBP较低。 IBWG和Hb仅在转换后的第一年上升,而P在第一年下降,但在最初的6个月没有上升。结论:与HD相比,HDF不能改善通过白蛋白,nPCR和BMI评估的营养。使用HDF时,Kt / V和磷控制效果更好,在对照组中观察到相似的结果。 HDF需要更大的EPO剂量才能维持相似的血红蛋白水平。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号